• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    1.64 Down 0.01(0.61%) 4:00PM EST
    |After Hours : 1.65 Up 0.01 (0.61%) 7:32PM EST
    Prev Close:1.65
    Open:1.67
    Bid:1.25 x 400
    Ask:1.68 x 1000
    1y Target Est:5.25
    Beta:2.67005
    Earnings Date:Feb 23 - Feb 29 (Est.)
    Day's Range:1.57 - 1.67
    52wk Range:1.39 - 9.37
    Volume:867,726
    Avg Vol (3m):2,381,320
    Market Cap:238.53M
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OREXDown 0.61%238.53M
    GSKUp 1.56%96.22B
    ABTUp 2.17%55.39B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.50
    Quarterly EPS Est (Dec-15) :-0.08
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):0.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback